B4GALT1 and Crohn disease: Consistent with this idea, the B4GALT1 enhancer SVA insertion is linked to a genomic region implicated by GWAS in both inflammatory conditions and autoimmune diseases such as systemic lupus erythematosus and Crohn’s disease (Lauc et al., 2013).